Hurel is a private, revenue-generating medtech company that uses cell biology and microfluidics to help drug companies predict early (i.e., pre-clinically) the
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free